Abstract

Epithelial ovarian cancer is the most severe gynecological cancers, with a low five-year survival, estimated at 35% at any stage (1). A true “silent killer” due to a late diagnosis almost always beyond all therapeutic resources, however, it has a good prognosis, when discovered at an early stage (stage IA at 90% and 70% at stage II) (1,2). Until the early 2000s, various theories on ovarian carcinogenesis were proposed, which focused on the ovary itself and its superficial epithelium with complex functional roles endowed with plastic properties and differentiation (3). Since 2001, new theories based on immunohistochemical and molecular studies have demonstrated the dominant role of the fallopian tube in the genesis of ovarian cancer (1,2).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.